BARDA Increases Contract Option with Cytori to Advance Countermeasure Clinical Trial - See more at: buff.ly/2ddYitT

CYTX licensee, Kerastem, completes US Phase II enrollment in STYLE clinical trial buff.ly/2cSwcWC $CYTX

ABEONA THERAPEUTICS ANNOUNCES DATA SAFETY MONITORING BOARD APPROVES ABO-102 DOSE ESCALATION buff.ly/2dKkqNV

buff.ly/2g2cgg4 Cytori Announces Two Year Follow-Up Published on EU Scleroderma Trial $CYTX

Sustained Clinical Benefit After 3 Year Follow Up in Scleroderma Trial buff.ly/2gV4JAG $CYTX

buff.ly/2hmwPY6 Cytori Pivotal ADRESU Incontinence Trial Hits 50% Enrollment Milestone $CYTX

buff.ly/2hArCtT President Obama Signs 21st Century Cures Act $CYTX #celltherapy

buff.ly/2hNYCAw Ronald Martell to Join Cytori Therapeutics’ Board of Directors $CYTX

buff.ly/2hNU6SC Cytori Announces Common Stock Purchase Agreement with Institutional Investor, Lincoln Park Capital Fund, LLC $CYTX

buff.ly/2iBDefV Cytori to Expand Scleroderma Focus to Broader Hand Therapy Franchise Under the Habeo™ Cell Therapy Brand $CYTX

buff.ly/2jGlEIN Cytori to Include Lupus Patients in Studies of Cell Therapy for Secondary Raynaud’s Phenomenon $CYTX

buff.ly/2iJVX8z Raynaud's Awareness Month is coming $CYTX

buff.ly/2jPgp9w Cytori to Acquire Proprietary Nanoparticle Development Platform to Enhance Regenerative Medicine Leadership $CYTX

buff.ly/2k7fGUL Cytori To Acquire Azaya Therapeutics $CYTX

SCLERADEC investigator Dr. Magalon featured in this month’s SRUK magazine #RaiseYourHands #KnowRaynauds #CheckOrphan $CYTX

SCLERADEC investigator Dr. Magalon featured in SRUK magazine #RaiseYourHands #KnowRaynauds #CheckOrphan $CYTX buff.ly/2jCAZJO

buff.ly/2lfYkCj Cytori taps Azaya for potential revenue, nanotech platform $CYTX #health #science #biotechnology

buff.ly/2kKAsZK Cytori Receives U.S. Small Business Designation - Substantially Reduces 2017 FDA Filing Fees $CYTX

buff.ly/2kOYmCT Cytori Provides Latest Corporate Update at the 2nd Annual Disruptive Growth & Healthcare Conference $CYTX

buff.ly/2lKFyGD Cytori Completes Acquisition of Azaya Therapeutics Assets, Initiates Nanomedicine Program $CYTX